|
1) Kepes J. Large focal tumor-like demyelinating lesions of the brain: intermediate entry between multiple sclerosis and disseminated encephalomyelitis: a study of 31 patients. Ann Neurol. 1993; 33: 18-27
|
|
|
|
2) Boppana M, Zagzag D. Central nervous system demyelinating presenting as a mass lesion: A diagnostic challenge. Ann Neurol. 1993; 34: 312
|
|
|
|
|
|
3) Masdeu JC, Quinto C, Olivera C, et al. Open-ring imaging sign: highly specific for atypical brain demyelination. Neurol. 2000; 54: 1427-33
|
|
|
|
|
|
4) Lucchinetti CF, Gavrilova RH, Metz I, et al. Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain. 2008; 131: 1759-75
|
|
|
|
|
|
5) Poser S, Luer W, Bruhn H, et al. Acute demyelinating disease. Classification and non-invasive diagnosis. Acta Neurol Scand. 1992; 86: 579-85
|
|
|
|
|
|
6) Comi G. Multiple sclerosis: pseudotumoral forms. Neurol Sci. 2004: 25; S374-9
|
|
|
|
|
|
7) Yapici Z, Eraksoy M. Bilateral demyelinating tumefactive lesions in three children with hemiparesis. J Child Neurol. 2002; 17: 655-60
|
|
|
|
|
|
8) 荒川博之, 河内 泉, 西澤正豊, 他. 腫瘍様変化を呈する多発性硬化症(MS), 急性散在性脳脊髄炎(ADEM)の臨床的検討. 神経免疫学. 2008; 16: 93
|
|
|
|
|
|
9) Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983; 13: 227-31
|
|
|
|
|
|
10) McDonald WI, Compson A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of multiple sclerosis. Ann Neurol. 2001; 51: 121-7
|
|
|
|
|
|
11) Weinshenker BG, Lucchinetti CF. Acute leukoencephalopathies: differential diagnosis and investigation. Neurologist. 1998; 4: 148-66
|
|
|
|
|
|
12) Kobayashi M, Ono T, Maruyama T, et al. Clinicopathological correlations of tumefactive brain lesions. Neuroradiology J. 2007; 49 (S2): S195
|
|
|
|
|
|
13) Mitha AP, Scott JN, Georg D, et al. Tumefactive demyelinating lesions. Can J Neurol Sci. 2007; 34: 362-4
|
|
|
|
|
|
14) Cha S, Pierce S, Knopp EA. Dynamic contrast-enhanced T2-weighted MR imaging of tumefactive demyelinating lesions. AJNR. 2001; 22: 1109-16
|
|
|
|
|
|
15) Erana-Rojas IE, Barboza-Quintana A, Ayala AG, et al. Demyelinating pseudotumor. Ann Diag Pathol. 2002; 6: 265-71
|
|
|
|
|
|
16) Given CA 2nd, Stevens BS, Lee C. The MRI appearance of tumefactive demyelinating lesions. AJR. 2004; 182: 195-9
|
|
|
|
|
|
17) Silver NC, Barker RA, MacManus DG, et al. Proton magnetic resonance spectroscopy in a pathologically confirmed acute demyelinating lesion. J Neurol. 1997; 244: 204-7
|
|
|
|
|
|
18) Ernst T, Chang L, Walot I, et al. Physiologic MRI of a tumefactive multiple sclerosis lesion. Neurol. 1998; 51: 1486-8
|
|
|
|
|
|
19) Khoshyomn S, Braff SP, Penar PL. Tumefactive multiple sclerosis plaque. J Neurol Neurosurg Pshychiatry. 2002; 73: 85
|
|
|
|
|
|
20) Butteriss DJ, Ismal A, Ellison DW, et al. Use of serial proton magnetic resonance spectroscopy to differentiate low grade glioma from tumefactive plaque in a patient with multiple sclerosis. Br J Radiol. 2003; 76: 662-5
|
|
|
|
|
|
21) 頼高朝子, 新井憲俊, 大田恵子, 他. 画像上脳腫瘍との鑑別を要した多発性硬化症の2例. 臨床神経. 2000; 40: 965
|
|
|
|
|
|
22) Tan HM, Chan LL, Chuah KL, et al. Monophasic, solitary tumefactive demyelinating lesion: neuroimaging features and neuropathological diagonosis. Br J Radiol. 2004; 77: 153-6
|
|
|
|
|
|
23) Placebo-controlled multicentre randomized trial of interferonβ-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferonβ-1b in secondary progressive MS. Lancet. 1998; 352: 1491-7
|
|
|
|
|
|
24) Champs Study Group. Interferon beta-1a for optic neuritis patients at high risk for multiple sclerosis. Am J Ophthalmol. 2001; 132: 463-71
|
|
|
|
|
|
25) Guilfoyle MR, Kirollos RW. Tumefactive demyelinating lesion. Neurol. 2007; 68: 2155
|
|
|
|
|
|
26) Keegan M, Pineda AA, McClelland RL, et al. Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology. 2002; 58: 143-6
|
|
|
|
|
|
27) Weinshenker BG. Therapeutic plasma exchange for acute inflammatory demyelinating syndrome of central nervous system. J Clin Apheresis. 1999; 14: 144-8
|
|
|
|
|
|
28) Lucchinetti CF, Bruck W, Parisi J, et al. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol. 2000; 47: 707-17
|
|
|
|
|
|
29) Haupts MR, Schimrigk SK, Brune N, et al. Fulminant tumefactive multiple sclerosis: Therapeutic implications of histopathology. J Neurol. 2008. In press(Epub)
|
|
|
|
|
|
30) 輿田純子, 村上龍文, 宮石雅浩, 他. 再発を繰り返したTumefactive MSの1例. 臨床神経. 2007; 47: 183
|
|
|
|
|
|
31) 前田敏彦, 古賀道明, 樋口文宏, 他. 脳外科手術後に急速に進行した腫瘍様多発性硬化症の65歳男性例. 臨床神経. 2007; 47: 183
|
|
|
|
|